We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
The U.S. Food and Drug Administration is unable to control the flow of unauthorized disposable vaping products into the country from China, The Associated Press reports. The number of e-cigarette devices sold in the U.S. has almost tripled to more than 9,000 since 2020.
The number of people with substance use disorders skyrocketed to 39.5 million globally in 2021, a 45% increase over 10 years, according to a new report from the U.N. Office on Drugs and Crime.
San Francisco could become the first U.S. city to require all its pharmacies to always carry the opioid overdose antidote naloxone, according to The Associated Press.
A new report from KFF Health News shows for the first time how much local governments are receiving from opioid settlements, revealing large differences among localities.
A coalition of criminal justice reform groups is urging the federal government to reconsider the Food and Drug Administration’s proposed ban on flavored tobacco products, The Hill reports. The groups warn the ban would lead to more overpolicing in communities of color.
View our curated digest of the latest research news, including a review of multidisciplinary strategies for preventing opioid use and escalation by targeting mental health symptoms and conditions for youth at high risk.
A new study finds just one-fourth of residential addiction treatment facilities that serve teens offers buprenorphine to treat opioid use disorder, STAT reports.
Almost 15% of U.S. children were treated for mental health disorders in 2021, according to new data from the Centers for Disease Control and Prevention.
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration, published national model standards for substance use, mental health and family peer worker certifications on Tuesday.
Indivior, the maker of the medication for opioid use disorder Suboxone, settled with multiple states and the District of Columbia for $102.5 million over its alleged anticompetitive practices, the Washington Post reports.
A new study found that over 80% of people in New York City who use substances tested positive for fentanyl, even though only 18% used it intentionally.
View our curated digest of the latest research news, including the association between nicotine vaping and other substance use among adolescents in the United States.
Find more of our must-reads in policy news, including a federal appeals court clearing the way for a Purdue settlement that protects the Sackler family from future lawsuits.
This website uses cookies. We use cookies and similar technologies to give you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
